Form 4: Imunon Director Frederick J. Fritz Acquires Stock Options in Lieu of Cash Compensation

Director Frederick J. Fritz acquired stock options in Imunon, Inc. in lieu of cash compensation for board fees.

Summary

• On September 10, 2024, Frederick J. Fritz, a director of Imunon, Inc., filed a Form 4 indicating a change in beneficial ownership.
• The transaction involved the acquisition of 6,737 stock options with an exercise price of $1.04.
• These options were granted on September 6, 2024, and vest over two years.
• The options were granted in lieu of cash for a portion of board fees.
• Following the transaction, Fritz directly owns 32,070 derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The director accepting stock options in lieu of cash suggests confidence in the company's future, but it's a routine transaction.

Positives

• Director's acceptance of stock options in lieu of cash may signal confidence in the company's future performance.
• The vesting schedule aligns the director's interests with the long-term success of the company.

Industry Context

Directors receiving stock options as part of their compensation is a common practice in the biotech industry, aligning their interests with shareholders and incentivizing long-term value creation.

Comparison to Industry Standards

• Stock option grants to board members are a common practice across the biotechnology industry.
• Companies like Amgen and Gilead Sciences also use stock options as part of their director compensation packages.
• The vesting schedule of 1/2 on the date of grant, 1/4 on the one-year anniversary, and 1/4 on the two-year anniversary is fairly standard.

Related Party Transactions

• The grant of stock options to Frederick J. Fritz, a director, is a related party transaction.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholders if it incentivizes the director to work towards the company's long-term success.

Key Dates

Keywords

Form 4, Imunon, Director, Stock Options, Beneficial Ownership, Compensation